Podcasts about welldoc

Wer ist Yves Nordmann? Dr. Yves Nordmann ist nicht nur praktizierender Kinderarzt mit eigener Praxis in Zürich, sondern auch einer der visionärsten digitalen Gesundheitsunternehmer Europas. Mit einem schweizerisch-israelischen Hintergrund und einer tiefen Verwurzelung in Medizin und Technik hat er Unternehmen wie Welldoc, Oviva, e-Medicus, docdok.health und docjo.health mitgegründet. Seine Mission: medizinisches Fachpersonal entlasten, Patient:innen empowern […] Der Beitrag Dr. Yves Nordmann über Vision, Daten und Vertrauen: Wie ein digital denkender Arzt unser Gesundheitssystem verändern will erschien zuerst auf Visionäre der Gesundheit.

This week on DisrupTV, we interviewed Anand Iyer, PhD, MBA, Chief AI Officer at Welldoc, Dr. Frederik G. Pferdt, Google's first (and former) Chief Innovation Evangelist and author of What's Next is Now: How to Live Future Ready and Jeff Wetzler, author of Ask: Tap Into the Hidden Wisdom of People Around You for Unexpected Breakthroughs in Leadership and Life. This episode of DisrupTV featured discussions on leveraging AI in healthcare, digital health, and future readiness. Anand Iyer, Chief AI Officer at Well Doc, highlighted AI's role in transforming diabetes care through digital therapeutics. He emphasized AI's potential in improving patient outcomes and efficiency. Frederik Pferdt, former Chief Innovation Evangelist at Google, discussed his upcoming book on future readiness, focusing on optimism, openness, curiosity, experimentation, and empathy. Jeff Wetzler, CEO of Transcend, shared insights on the importance of asking questions to tap into hidden wisdom, advocating for a culture of curiosity and learning. Here are some of the questions we touched on:

In this episode, we highlight two companies that leverage data from many different sources to create a more complete picture of a person's health. The ultimate goal? Shifting away from the current model of “sick care” - where patients primarily see their doctors when they aren't feeling well – to care models that prioritize long-term health and self-management with guidance from providers. These companies are helping lead the way to value-based care, from using AI to sift through patient-reported data and provide actionable insights, to integrating NCQA's HEDIS measurements into their data platform, thereby putting quality at the center of everything they do. Here, you'll get a glimpse into the challenges and opportunities in our current data-rich health care ecosystem.The episode begins with a conversation with leaders from Welldoc. Welldoc is a health tech company developing patient-facing apps to support self-management of chronic conditions. Using an omnichannel approach, their apps gather as much data as possible from sources including remote monitoring devices, like wearables, and clinical data.Chief Analytics Officer, Dr. Anand Iyer, and Chief Medical Officer, Dr. Mansur Shomali, explain how Welldoc uses AI to parse the patient information, ultimately helping doctors and patients work together to construct an effective path to wellness.Jessica Robinson is Chief Platform Officer for health care digital developer The Garage. Jessica manages all aspects of the product life cycle, from the spark of innovation through design, development, testing, and roll-out. Founded in 2012, The Garage aims to utilize digital tools to help providers shift from fee for service models to value-based models of care.In this interview, recorded live at NCQA's 2023 Health Innovation Summit, Jessica explains how The Garage works with Management Service and Accountable Care organizations, among other provider groups, to develop digital applications that help clinically integrated networks across 34 states harness the full extent of the population data available to them. The Garage also utilize NCQA's HEDIS measures into their platform, allowing networks to visualize the full patient care team across the entire care continuum and deliver optimized quality care to their patients.For information on NCQA's Health Equity Forum, click here: https://events.ncqa.org/healthequityforum

To celebrate the end of 2023, hosts recap the top 10 episodes of the past year and offer perspective on how the news discussed in these episodes has shaped the future of diabetes management. Episode Highlights 00:32 Automated Insulin Delivery News in October 2023 04:35 Breaking Down AACE's New Type 2 Diabetes Management Algorithms 06:45 What Medicare Drug Price Negotiations Mean for Diabetes  09:15 STEP-HFpEF Reaction  12:10 Dexcom G7 and the Future of CGM, with Jake Leach 13:20 Tandem Mobi and Welldoc's BlueStar Platform 16:20 Making Sense of Semaglutide in Type 1 Diabetes 18:35 Establishing Time in Range as a Primary Glucose Metric 21:15 TRANSITION-T2D, with Paloma Rodriguez, MD, and Kevin Pantalone, DO  25:15 What to Know about the iLet Bionic Pancreas

Hosts discuss their experience interacting with the Tandem Mobi pump from the ADCES 2023 meeting and offer perspective on what the Welldoc clearances mean for people with diabetes and care providers. Video Version: https://www.hcplive.com/view/diabetes-dialogue-tandem-mobi-and-welldoc-bluestar-platform

Masimo this week announced the launch of its Stork home baby monitoring system. Fast Five hosts Sean Whooley and Danielle Kirsh explain how the system works and how it fits in with the flagship products already with the company. Home hemodialysis is on the rise. Fresenius Medical Care recently received FDA 510(k) clearance for its Versi HD with GuideMe software for its chronic home hemodialysis system. Find out when the technology will become available and how executives envision it for use in the home in today's episode. Diabetes care devices are consistently innovating, and Welldoc's continuous glucose monitoring is having an exceptional month. Just a week after it received its tenth FDA clearance, Welldoc has received its 11th FDA clearance for its BlueStar digital diabetes management platform. Whooley details what makes this clearance unique and what the clearance allows the company to do. Johnson & Johnson is placing more focus on its MedTech and Pharmaceutical division by splitting off its Kenvue consumer health business. The Fast Five hosts share the results of the split off and what executives are saying. Renal denervation is a hot topic in medtech right now with varying opinions on its success. This week, an FDA panel voted unanimously in favor of the safety and efficacy of Recor Medical's Paradise ultrasound renal denervation system. Find out what data was included in the PMA submission and what executives are saying. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

People living with diabetes are always looking for ways to make the management of their chronic condition easier. Welldoc aims to address that with its BlueStar platform, which just received its 10th FDA clearance, this time for using connected insulin dosing data in personalized bolus insulin dosing recommendations. Fast Five hosts Sean Whooley and Danielle Kirsh break down what BlueStar does and how this latest regulatory nod boosts Welldoc. The episode also covers FDA authorization for another innovative technology — Viz.ai's artificial intelligence-based module for detecting hypertrophic cardiomyopathy. The FDA's de novo nod creates a new regulatory category for cardiovascular machine learning-based notification software. Learn about how this module works as another AI-based technology garners regulatory approval. Meanwhile, Viseon says it began the U.S. commercial rollout and initial clinical use of its MaxView 4K advanced visualization system. The company describes MaxView 4K system as a first-of-its-kind advanced visualization system for minimally invasive spine surgery. Hear about what this technology does that makes surgeons call it a "game-changer." Microbot Medical, maker of the Liberty surgical robot, entered into a manufacturing deal with B.Y. Medimor. This could prove a significant milestone as the company looks to garner regulatory approvals for its robot before a commercial rollout. Find out more about what the robot does and how Microbot is looking at the next steps. The FDA revealed another Class I recall — the most serious kind — for ventilators made by Philips Respironics. This one, while unrelated to the recall that knocked the company out of the sleep respiratory market more than two years ago, still led to some serious outcomes, including injuries and a death. Learn more about what caused this recall and how many people it's affected in the U.S. to date. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.

How can AI innovation help in transforming the future of Endocrinology? What are the main problems we have with the US healthcare system, and what roles can MDs have in solving these problems? In this episode, we answer all these questions and more, with our guest, Mansur Shomali, M.D. He is Chief Medical Officer at Welldoc, a healthcare technology company that develops solutions to transform the management of chronic disease. Mansur received his undergraduate degree in biomedical engineering at the Johns Hopkins University and his medical degree from McGill University in Montreal, Canada.

Daniel Rosenberg speaks frankly about executive design leadership, why he's trying to take the field back to first principles, and how the sun is setting on design as we know it. Highlights include: ⭐ Which Jedi would Don Norman say is most like you? ⭐ How did your first presentation to Larry Ellison at Oracle go? ⭐ Why is design education being overly intuitive a problem? ⭐ What is Semantic IxD and why is it important? ⭐ How do you remove enemies while maintaining moral authority? ====== Who is Daniel Rosenberg? Daniel is the Chief Design Officer at r-CDO and during his 40+ year career, he has forged a near unparalleled path as a world-leading and highly respected UX practitioner, global design executive, consultant, author and educator. Recently, Daniel has been working at the intersection of AI and interaction design, advising a number exciting startups, including WellDoc, CanSurround, Workato and Kleeen Software. Before starting r-CDO, Daniel was the top UX executive at Oracle where he served as VP of UI Design, and then at SAP, where he was SVP of Global User Experience.  Prior to joining Oracle, while he was at Ashton-Tate and then Borland, Daniel invented several design patterns that are still popular in product design today, including tabbed UI. Daniel's latest book UX Magic was published in 2020; a groundbreaking book that lays out a complete system for Semantic Interaction Design. ====== Find Daniel here: LinkedIn: https://www.linkedin.com/in/danielrosenbergux/ Website: https://rcdoux.com/ ====== Liked what you heard and want to hear more? Subscribe and support the show by leaving a review on Apple Podcasts (or wherever you listen). Follow us on our other social channels for more great Brave UX content! YouTube: https://www.youtube.com/TheSpaceInBetween/ LinkedIn: https://www.linkedin.com/company/the-space-in-between/  Instagram: https://www.instagram.com/thespaceinbetw__n/  ====== Hosted by Brendan Jarvis: LinkedIn: https://www.linkedin.com/in/brendanjarvis/ Website: https://thespaceinbetween.co.nz/ Twitter: https://twitter.com/brendanjarvis/

HealthIMPACT Live Presents: Keynote Case Study: Integrating Chronic Care Digital Health Platform into Large Safety-Net Hospital System Originally Published: Nov 15, 2021YouTube Video: https://www.youtube.com/watch?v=mdpEyA_BdpQJoin this fireside chat with Keith Reynolds, Chief Operating Officer from Welldoc and Dr. Karyn Singer, MD MPH, AVP of Chronic Disease and Prevention from New York City Health and Hospital System (NYCHH), to discuss their journey integrating digital health into the care model and the direct impact this had for patients. NYCHH estimates that half of their patients with diabetes are unable to achieve their glycemic targets. NYCHHC integrated a digital health solution into their existing program in order to tackle this problem and improve self-management among a diverse population living with diabetes. In this session, the speakers will dig into the challenges and lessons learned from integrating digital health into their chronic care model. In this fireside chat, we will discuss: The value of integrating digital health into the care model What it takes to successfully implement a digital health solution into a large safety-net hospital system Meeting the needs of a diverse patient population Meaningful engagement to support better health Karyn Singer, MD MPH, New York City Health and Hospital System (NYCHH), AVP of Chronic Disease and PreventionKeith Reynolds, COO, WelldocShahid Shah, Publisher and Chief Editor, Medigy.com, Moderator

Doing what's good for you should seem like second nature, so why is it that we as humans so often don't do things which we know will be effective when it comes to our own health and wellbeing? From difficulties in quitting smoking to the 25% of prescriptions in the UK that are left unfilled, medical non-adherence has profound effects on the health of a population, and it's also one of the trickiest realms for health practitioners to deal with. How do you literally change someone's behaviour if they already know they're doing themselves harm? Find out on this week's episode of Invent: Health from TTP.This Week's GuestsPaul Upham is the Head of Smart Devices at Roche / Genentech and has over 20 years of experience in medical technology and digital health in R&D as well as global marketing and product management roles, including leading the development of the world's first prescription digital therapy for type 2 diabetes, Bluestar, from WellDoc.https://www.linkedin.com/in/paulupham/Dan Lock is a consultant in psychology and human factors at TTP. A psychologist by background, Dan leads on understanding the users of our products, exploring their motivations and figuring out those design features that translate into long-term adherence to medication.https://www.linkedin.com/in/danlock/Dr. Olga Perski is an interdisciplinary scientist working at the intersection of behavioural science and digital health. She is a health psychologist by training and completed her PhD at University College London in 2018, with a thesis on the definition, measurement and promotion of user engagement with digital behaviour change interventions. She is a post-doc in the UCL Tobacco and Alcohol Research Group and a UCL Centre for Behaviour Change Associate. Her work is focused on the development and evaluation of digital interventions for smoking cessation and alcohol reduction.https://www.olgaperski.com/The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients. Find out more about our work here: https://ttp.com/invent

We're raised to believe that right and wrong are fixed concepts. But the truth is, ethics change over time. And technology moves the goalposts on what we consider to be ethical behavior. Juan Enriquez is a leading authority on the economic impact of life sciences on business and society, and as Managing Director of Excel Venture Management, he sits on the boards of innovative healthcare startups like Openwater, WellDoc and Zipongo. Juan is the bestselling author of As the Future Catches You: How Genomics & Other Forces Are Changing Your Life, Work, Health & Wealth, and his latest release is called Right/Wrong: How Technology Transforms Our Ethics. On this episode of The Wiggin Sessions, Juan joins me to share his fears around antibiotic resistance in the aftermath of COVID-19 and discuss how the pandemic exacerbated the political and societal divisions he predicted in The Untied States of America as a long-term consequence of the financial crisis. Juan describes the synthetic genomics powering our future, explaining how factory and agricultural systems are likely to transform in what he calls the Century of Biology. Listen in for Juan's insight on reinventing the American Dream and learn how technology changes our perspective of right and wrong—and why we need to judge our ancestors and each other through a lens of context and grace. Key Takeaways Juan's fears around antibiotic resistance in the aftermath of COVID and the possible return of diseases like dengue, tuberculosis and malaria How the pandemic accelerated trends around debt, inequity, societal division and risk-taking in the financial markets How Juan predicted the political and social divisions we're experiencing now as long-term consequences of the financial crisis How technology changes our perspective of what is right and wrong (and why we need to judge our ancestors with context and grace) What happens when societies or religions don't support and adapt to innovation Juan's take on the evolution of capitalism and the need to reinvent the American Dream in a digital age The work Synthetic Genomics is doing to edit genes within bacteria to produce methane (and how it benefits the environment) The race between quantum computing and the biological storage of information How the factory system and agriculture are likely to transform in what Juan calls the Century of Biology How Excel Ventures enables entrepreneurs to solve big problems (i.e.: healthy food systems, medical imaging, diabetes management, etc.) What Juan looks for in a healthcare or life sciences company and the startups that are part of his portfolio The four factors that influence healthcare costs and why prevention vaccines are one of the most effective uses of public dollars Why it's dangerous to short-circuit the clinical trial process for vaccines for political purposes Connect with Juan Enriquez Excel Venture Management Right/Wrong: How Technology Transforms Our Ethics by Juan Enriquez Connect with Addison Wiggin Consilience Financial Be sure to follow The Wiggin Sessions on your socials. You can find me on— Facebook @thewigginsessions Instagram @thewigginsessions Twitter @WigginSessions Resources Evolving Ourselves: How Unnatural Selection and Nonrandom Mutation are Changing Life on Earth by Juan Enriquez and Steve Gullans As the Future Catches You: How Genomics & Other Forces Are Changing Your Life, Work, Health & Wealth by Juan Enriquez The Untied States of America: Polarization, Fracturing and Our Future by Juan Enriquez Synthetic Genomics Openwater WellDoc Zipongo Orionis Biosciences InfoBionic Mary Lou Jepsen's TED Talk Moderna Regeneron Pharmaceuticals Gilead Sciences INOVIO Pharmaceuticals

In this special edition of Diabetes Technology three diabetes experts join us to discuss to potential for improvement in care of persons with diabetes with the use of diabetes technology.    This special edition is supported by unrestricted educational grants to the American Diabetes Association from Abbott Diabetes Care and Dexcom. For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Mansur Shomali, M.D, founding physician of the Diabetes & Endocrine Center at MedStar Union Memorial Hospital in Baltimore, MD, Adjunct Associate Professor of Medicine at the University of Maryland School of Medicine in Baltimore, and Chief Medical Officer at Welldoc. Eden Miller, D.O., Executive Director and Co-Founder of Diabetes Nation and in practice at Diabetes and Obesity Care, St. Charles Hospital, Bend, Oregon.  Eugene Wright, M.D. Medical Director for Performance Improvement at the Charlotte Area Health Education Center. 

On the last episode, I got to know Anand Iyer, Chief Strategy Officer at WellDoc, who was instrumental in getting the Digital Therapeutics Alliance up and running. In this episode, the focus on the early trailblazers of the DTx industry continues with Eddie Martucci. Eddie is the CEO and founder of Akili Interactive, which has taken a super interesting go to market approach. I very briefly met Eddie, at a small event during the JPMorgan conference in San Francisco years ago. Eddie's energy and passion for the product exuded while he was showing a crowd of onlookers an early version of a game that is now an actual digital therapy, EndeavorRx Click here to read the transcript Guest Links and Resources: Connect with Eddie Martucci: Twitter | LinkedIn Visit Akili Interactive Labs Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

In this episode, we speak with another one of the early trailblazers of the DTx industry, Anand Iyer, the Chief Strategy Officer of Welldoc. I briefly met Anand at a Health XL event in New York City early in 2019, even though Welldoc has been around since 2008. I'm not even sure how we did not run into each other before, but it was great to connect with Anand for this podcast and get to know him and what drives him, not to mention speak about the early days of Welldoc and DTx industry. Click here to read the transcript Guest Links and Resources: Connect with Anand Iyer: Twitter | LinkedIn Visit Welldoc Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn HealthXL: Website | Twitter | Join an Event Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to: Bayer G4A Cedars-Sinai Accelerator Takeda Roche

In this Fireside Chat, Natalie Yeadon, Co-Founder and CEO of Impetus Digital sits down with Anand Iyer, Chief Strategy Officer at Welldoc and discusses a myriad of different topics, including AI and MR in healthcare and Anand's predictions for how the roles and types of digital health technologies will change in the post-COVID new normal. They also dissect interesting topics such as how mobile prescription therapy works as a supplement to behavioral interventions and pharmacotherapy, and different ways to leverage healthcare data.Schedule a meeting with Natalie Yeadon: https://www.meetwithnatalie.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/ImpetusadboardsImpetus YouTube: https://www.youtube.com/ImpetushealthcareAnand Iyer: https://www.linkedin.com/in/anand-iyer-b294b64/Welldoc: https://www.welldoc.com/

Recorded on 06-17-20 Join us as we speak with Chief Strategy Officer of Welldoc Anand Iyer who played a key role in the development of Welldoc's BlueStar, the first FDA-cleared mobile prescription therapy for adults with type 2 diabetes. Podcast episode hosted by Cowen's Health Care Technology Analyst Charles Rhyee. For Disclosures, click here bit.ly/3cPHkNW

Harnessing the power of A.I. to scale digital care for chronic disease management

Here’s a vital question, “How do you make sure that the physicians your employees or members are seeing are high quality in a given area of focus?” Getting to the right doctor matters when you consider that something like 70% of back surgeries are unnecessary and medical errors are the third leading cause of death in this country. And also because, as Suzanne DelBanco put it in EP224, if a payer simply cuts out the bottom performing 10% of practices, the returns are outsized from a cost and quality perspective. The challenge is how to actually accomplish this. How to measure quality in a sea of dirty data and noise and whatever the opposite of interoperability and aggregated data sets is. With the confounding factor also that outcomes are rarely if ever included in data sets, especially when you consider that the outcomes that matter to patients are really the outcomes that count. Today I speak with Suzanne Clough, MD. In a former life, Suzanne was a co-founder of Welldoc, the first FDA-approved digital health platform and also featured on EP102 of this podcast. Now, Suzanne is the chief-medical officer over at ArmadaHealth, a company that aims to become a GPS for health care helping to get patients to the right doctor quicker. You can learn more at www.armadahealth.com Dr. Suzanne Sysko Clough, MD, is Chief Medical Officer of ArmadaHealth, a health and data science company that navigates consumers to quality health care providers using big data, AI, and proprietary quality algorithms that together produce 360-degree profiles of physicians. The platform enables precision matching of physicians with patients based on diagnosis/condition and nonclinical attributes. Before ArmadaHealth, Suzanne was a co-Founder and Chief Medical Officer of WellDoc, the first FDA-approved digital health platform. Dr. Clough completed her medical training in internal medicine and a fellowship in endocrinology at the University of Maryland Medical Systems and served as an assistant professor in the Division of Endocrinology as well as Medical Director and as the Founder and Medical Director of the Center for Weight Management and Wellness. 02:10 Why finding the right provider is so important. 03:01 Higher quality health systems or the need for wider specialty coverage? 03:59 “We don’t recognize that there can be a quality...difference among physicians and...among health systems.” 06:08 Quality as the intersection of clinical acumen and the ability to form a relationship. 07:18 Determining what is or isn’t appropriate. 08:11 When it seems appropriate from a physician standpoint but isn’t from a patient standpoint. 11:01 When physicians could use more support. 11:49 Practicing wisely. 14:36 Do payers care about getting patients to the right doctor? 17:00 Center of Excellence model vs insurance policy methods. 23:06 “We’re not empowering people with the right information.” 23:41 How ArmadaHealth’s approach is different. 24:27 Claims data vs clinical data and outcomes data. 27:06 How ArmadaHealth pairs patients with physicians. 31:00 Who ArmadaHealth is deployed by. 31:31 Who ArmadaHealth gets their outcomes data by, and why this is important to assessing patient quality care. You can learn more at www.armadahealth.com Why is finding the right #provider so important? Suzanne Clough of @ArmadaHealth discusses on our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata Higher #quality #healthsystems or the need for wider #specialtycoverage? Suzanne Clough of @ArmadaHealth discusses on our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata “We don’t recognize that there can be a quality...difference among physicians and...among health systems.” Suzanne Clough of @ArmadaHealth discusses on our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata #Quality as the intersection of #clinicalacumen and the ability to form a relationship. Suzanne Clough of @ArmadaHealth discusses on our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata What is and isn’t appropriate for a #physician #diagnosis and #treatment? Suzanne Clough of @ArmadaHealth explains on our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata When a treatment seems appropriate from a #physician standpoint but isn’t from a #patient standpoint. Suzanne Clough of @ArmadaHealth discusses on our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata In what area could #physicians use (arguably) the most support? Suzanne Clough of @ArmadaHealth discusses on our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata Practicing wisely. Suzanne Clough of @ArmadaHealth discusses on our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata Do #payers care about getting #patients to the right #doctor? Suzanne Clough of @ArmadaHealth discusses on our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata Center of Excellence model vs insurance policy methods—Suzanne Clough of @ArmadaHealth discusses on our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata “We’re not empowering people with the right information.” Suzanne Clough of @ArmadaHealth discusses on our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata How is @ArmadaHealth’s approach different? Find out in our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata Claims data vs Clinical data and outcomes data - Suzanne Clough of @ArmadaHealth discusses on our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata How does @ArmadaHealth pair #patients with #physicians? Find out in our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata Why is #outcomesdata so important to assessing #patient #qualityofcare? Suzanne Clough of @ArmadaHealth discusses on our #healthcarepodcast. #digitalhealth #healthcare #podcast #clinicaloutcomes #patientjourney #healthdata

Last time I looked this up online, there were more than 5000 companies offering digital medicine tools. Which ones worked? Which ones are less good than others? Which ones have not been tested? How were they tested: apples to apples or a whole fruit basket of standards? If you’re a clinician or the head of population health or an insurance carrier and you’re trying to figure out whether a digital tool could help solve a problem your patients are having … at this juncture, may the force be with you and I hope you know how to use Excel. The Digital Therapeutics Alliance (DTA) aims to put definitions and standards around what can be legitimately called a digital therapeutic and how these tools are best deployed so that patients are best equipped to get the best possible outcomes. Today I speak with Megan Coder, executive director of the Digital Therapeutics Alliance. You can learn more at dtxalliance.org. Megan Coder, PharmD, MBA, is executive director of the Digital Therapeutics Alliance (DTA), whose mission is to broaden the understanding, adoption, and integration of clinically validated digital therapeutic solutions into mainstream health care through education, advocacy, and research. With more than a decade of experience in the health care industry, Megan’s expertise extends from strategic growth and partnership development within the digital health sector to the direct delivery of patient care. 01:50 What the Digital Therapeutics Alliance is. 02:59 Defining a digital therapeutic. 03:50 What is vs what isn’t a digital therapeutic. 05:08 What it means to be a digital therapeutic. 06:19 Extending clinical care to a patient outside of the clinical care environment. 07:54 Digital therapeutics Megan is currently excited about. 10:48 Learn more about WellDoc with Anand Iyer in EP102. 11:02 Learn more about Propeller Health in EP32 with Kevin Houlihan. 12:05 Digital therapeutics and digital formularies. 13:09 Managing and prescribing digital therapeutics on an individual patient level. 15:22 Why the DTA exists and the questions it’s answering. 18:09 Legitimate claims vs really good marketing. 20:34 “How do we start to clarify that process and bring a little … more continuity and consistency into this world?” 22:57 Disrupting without interrupting. 25:24 Megan’s advice to providers: knowing clinical needs and gaps. 27:31 Megan’s advice for insurance carriers. 28:32 Love the problem, not the solution. You can learn more at dtxalliance.org.

William Gibson, the noted science fiction author wrote, "the future is already here, it’s just not widely distributed yet."  Our guest this week describes a future revolution in healthcare that is, in fact, already here.  Digital health therapeutics are transforming the delivery and experience of medical care and rapidly gaining traction in healthcare delivery.Anand Iyer, the Chief Strategy Officer for Welldoc, has been engaged in digital health for well over a decade.  He is a respected global digital health leader.  Anand has a doctorate in computer and electrical engineering as well as a MBA from Carnegie Mellon.  Anand and his colleagues are part of a large and growing community of cutting-edge digital entrepreneurs that are building the technologic infrastructure and capabilities to enable a completely different approach to medical care.  In this interview, Anand describes the digital therapeutics that are being used to provide clinical care to patients with chronic diseases such as diabetes and hypertension.  To date, Welldoc’s FDA approved digital therapeutic, Blue Star, has been used by tens of thousands of healthcare consumers with diabetes.In addition, in this episode Anand shares the following:How digital health software and algorithms are becoming FDA-approved and regulated therapeutics, similar to medications and medical devices.The three main facets of the Blue Star digital health program - targeted at patients, providers and health systems.The requirements for the acceptance and adoption of digital health into mainstream clinical delivery.Why digital health is the only viable option in addressing numerous chronic diseases that are advancing at epidemic proportion.Why digital health presents a great solution to some of the challenges in providing optimal care to the Medicaid population - addressing some of the existing inequities in quality, accessibility, affordability and engagement.How different digital health platforms are beginning to coalesce, affording users a singular, non-fragmented, seamless experience.It is remarkable that Anand and his colleagues understood this potential well over a decade ago - the use of digital apps to treat diabetes, hypertension, depression, heart failure and numerous other chronic diseases.  Given their forethought, Anand asks us to imagine what digital technology and advanced analytics will be able to accomplish in the next 5 years. The use of: 24/7 real-time biometric recording and psychosocial/consumer information; coupled with machine learning, artificial intelligence, predictive analytics, voice technologies, natural language processing and avatars; plus new coordinating & integrating operating platforms - will enable unimagined advances in medical care.  Three closing thoughts:The take-home point is that digital health will almost certainly be a profound (and perhaps unprecedented) enabler in making high-quality healthcare accessible, affordable and sustainable - for everyone.Digital health will also be a major enabler in engaging healthcare consumers, finally breaking the quality & outcomes barrier we’ve been unable to penetrate over the past couple of decades.  Although digital technology is going to be a game-changing enabler, our purpose should not be to digitize healthcare, but to humanize it.As always, I am very interested in hearing your thoughts about this exciting domain of creating a new healthcare.This will be one of a number of upcoming interviews focused on digital health.Until next time, be well!Zeev 

Candy Barnes owns an architectural design company in Virginia Beach, Virginia. To her surprise, she was diagnosed with type 2 diabetes a little over a year ago. Her hemoglobin A1c at diagnosis was over 11% (which means her average blood sugar was above 300 mg/dL) and was immediately put on insulin. Candy was very motivated to take care of herself and was able to do so with the help of a digital health tool called BlueStar. Her background in home economics and her desire to enjoy her grandchildren growing up were also key to her success. Today her A1c is down below 6% (which means her average blood sugar is below 126 mg/dL; 5.6 and below is considered “normal” blood sugar). She no longer takes insulin. She’s on a small dose of metformin and has lost about 50 lbs.  Hope Warshaw is a dietitian and certified diabetes educator. She’s been in the field of nutrition and diabetes as a consultant, counselor and writer for nearly 40 years. Hope is the author of several books published by American Diabetes Association. Eat Out, Eat Well and Diabetes Meal Planning Made Easy are her two most current books. Hope is a consultant to WellDoc, the developer of BlueStar. Tune in to the show to find out: What symptoms Candy had How home economics classes helped Candy create her own 5-day menu How Candy was able to lose 50 pounds What the BlueStar app entails The best thing about digital health tools like BlueStar How healthcare providers are using digital health tools to monitor and manage diabetes  For the full show notes and resources visit www.SoundBitesRD.com   

Dr. Suzanne Clough is the Chief Medical Officer at Amalgam Rx and Chief Innovation Officer at ArmadaHealth. In her free time, Suzanne revels in the pleasant chaos of her house with her husband, two children, and two dogs. She is also an athlete who enjoys basketball, swimming, and cycling. Suzanne is a physician by training, but she has been dedicating her efforts in recent years to investigating the behavioral science and psychosocial aspects of being a patient. She is working to discover what motivates people to engage in their healthcare, what creates barriers, and what can help people build reduce stress and build resilience. Through her companies, Suzanne develops digital health solutions that help people better manage their chronic diseases, improve their healthcare experience, and live happier lives. She received her bachelor’s degree in Biology from James Madison University and her medical degree from the University of Maryland School of Medicine. She completed her residency and an endocrinology fellowship at the University of Maryland Medical System. Afterwards, Suzanne worked as an Endocrinologist within the University of Maryland Medical System, as well as a faculty member and Medical Director for the Center for Weight Management and Wellness at the University of Maryland School of Medicine. Afterwards, she co-founded the mobile health company WellDoc and served as its Chief Medical Officer until 2016 when she began her current endeavors. Suzanne joined us for an interview to share her experiences in life and in her career.

Anand is a respected global digital health leader—most known for his insights on and experience with technology, strategy and regulatory policy. Anand has been instrumental in WellDoc's success and the development of BlueStar®, the first FDA-cleared mobile prescription therapy for adults with type 2 diabetes. Since joining WellDoc in 2008, he has held core leadership positions that included Chief Data Science Officer, President and Chief Operations Officer. In 2013, Anand was named “Maryland Healthcare Innovator of the Year” in the field of mobile health. Prior to joining WellDoc, Anand was already an established thought leader in the field. He had served as the Director of PRTM's wireless practice, where helped companies take advantage of disruptive technologies, business models and process models offered by and enabled by advanced wireless communications. Anand was the founder and immediate-past president of the In-Building Wireless Alliance, and teaches advanced wireless courses to senior officers in the US Department of Defense at the Institute for Defense and Business. Prior to joining PRTM, Anand was a member of the scientific staff at Bell Northern Research and Nortel Networks. He holds an MS and a PhD in electrical and computer engineering, and an MBA from Carnegie Mellon University. He also holds a BS in electrical and computer engineering from Carleton University. 00:00 Stacey and Anand discuss the term ‘disruptive,' and its changing relevance. 02:10 “Don't fight forces, use them.” - Buckminster Fuller 03:30 “Digital Health is disruptive to the system, but it's not disruptive to the user.” 04:45 “You want to be disruptive to health outcomes, or else you're actually adding cost.” 05:00 “The Digital Doctor,” by Robert Wachter 05:45 Creating a seamless and uninterrupted patient experience without disrupting the provider view. 08:50 “We are enamored with Big Data.” 09:50 Data not as an end, but as a means to an end. 10:40 Driving Patient Data, faster. 11:00 “We shouldn't stop at just Data collection.” 11:30 Thinking about turning Data into relevant action. 14:00 Discovering a pattern of interest. 15:45 Digital Health as additional fidelity. 16:30 Optimizing the use of artificial intelligence. 17:45 Identifying patterns vs. utilizing them. 19:30 Where WellDoc fits in the IDEA model. 23:00 Bringing the Patient and the Provider closer together. 23:30 Integrated Delivery Networks. 26:00 Being a Life Science Company. 28:30 You can find out more at www.WellDoc.com and www.BlueStarDiabetes.com.

Dr. Blaine Warkentine is a true leader in health who has been involved in multiple different elements of the industry. A Physician-entrepreneur, Blaine's most recent endeavor is called Vimty, which focuses on end of life care planning. Prior to his current company, Blaine either founded or held leadership positions in companies like SurgeryTrack, Innovation Thrives, Fitness Builder, InVivoLink, and WellDoc to name just a few. Blaine's passion for improving health revolves around building and harnessing innovation strategies, user data, engagement, design principles, and rapid iterative product development to test hypotheses about solving some of health's biggest problems. Blaine completed his medical orthopedic residency at the University of Maryland and his fellowship in sports medicine at the Long Beach Memorial Medical Center.In this interview, Dr. Warkentine provides great insights into the world of health, being an entrepreneur, his philosophy of B2C4B, the importance of palliative care and end of life arrangements, and the intersection of health and technology including the revolution that was introduced by the iPhone.

Guest: Suzanne Clough, MD Host: Susan Dolan, RN, JD Dr. Suzanne Sysko Clough is the Chief Medical Officer of WellDoc Communications, a technology based healthcare company located in Baltimore, Maryland. Hear Dr. Clough as she discusses how the WellDoc cell phone-based technology helps patients manage their diabetes.